The use of fibrin sealant in CABG surgery. A pilot study.

The use of fibrin sealant in CABG surgery. A pilot study. - Fibrin sealant in CABG surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30606

Enrollment

Registered

2007-03-15

Start date

2007-01-15

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bloedingen coronary artherosclerosis stenosis of cardiac arteries

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: CABG patients with a minimum age of 18 years Revisions of CABG

Exclusion criteria

Exclusion criteria: Patients with congenital or acquired coagulation deseases Patients with thrombopenia,

Design outcomes

Primary

Measure	Time frame
Numbers of bleedingstops/complete hemostasis, at least 5 minutes after restoration of the blood flow.	—

Secondary

Measure	Time frame
Number of anastomoses Number of bleedings stopped Nummer of bloedtransfusies Amounts of ml fibrin sealant applied	—

Countries

Netherlands

Outcome results